Vibe Growth Corporation Stock Canadian Securities Exchange
Stocks
VIBE
CA92556L4055
Drug Retailers
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
21:09:12 01/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.5500 CAD | +17.02% |
|
0.00% | - |
| Market Cap | 359K 319K 298K 272K 511K 34.57M 518K 3.6M 1.4M 17.62M 1.35M 1.32M 56.73M | P/E 2024 |
-0.09x | P/E 2025 | -0.18x |
|---|---|---|---|---|---|
| Enterprise Value | 2.07M 1.84M 1.72M 1.57M 2.94M 199M 2.99M 20.76M 8.05M 102M 7.77M 7.6M 327M | EV / Sales 2024 |
0.16x | EV / Sales 2025 | 0.12x |
| Free-Float |
63.42% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| VIBE | End-of-day quote | |
Canadian Securities Exchange
| VIBE | Delayed | |
OTC Markets
| VIBEF | Delayed | |
Deutsche Boerse AG
| 3ST0 | Delayed |
| 1 week | 0.47 | 0.55 | |
| 1 month | 0.42 | 0.55 | |
| 3 years | 0.3 | 7 | |
| 5 years | 0.3 | 53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Waldron
CEO | Chief Executive Officer | 58 | 25/03/2019 |
Michal Holub
DFI | Director of Finance/CFO | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Waldron
BRD | Director/Board Member | 58 | 25/03/2019 |
Joe Starr
BRD | Director/Board Member | - | 13/10/2020 |
Aaron Johnson
BRD | Director/Board Member | - | 22/08/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +17.02% | 0.00% | - | - | 357K | ||
| -0.11% | +0.06% | -45.86% | -11.33% | 14.63B | ||
| +1.63% | +1.52% | +4.74% | -30.22% | 6.2B | ||
| -0.95% | -3.03% | -11.47% | +4.33% | 6.1B | ||
| +0.51% | -3.18% | -18.49% | -8.66% | 6.1B | ||
| +1.42% | +1.06% | -56.98% | -41.29% | 5.9B | ||
| +1.30% | +5.52% | -5.44% | -20.24% | 4.21B | ||
| +0.11% | -0.05% | -23.45% | -36.82% | 3.15B | ||
| +0.94% | -3.50% | -28.11% | -18.78% | 3.1B | ||
| +2.08% | +1.28% | +10.37% | -27.63% | 3.09B | ||
| Average | +0.77% | -1.42% | -19.41% | -21.18% | 5.83B | |
| Weighted average by Cap. | +0.56% | -1.51% | -25.01% | -18.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.71M 11.31M 10.57M 9.64M 18.08M 1.22B 18.35M 128M 49.44M 624M 47.73M 46.7M 2.01B | 17.23M 15.32M 14.32M 13.06M 24.51M 1.66B 24.87M 173M 67M 846M 64.69M 63.28M 2.72B |
| Net income | -6.54M -5.82M -5.43M -4.96M -9.3M -630M -9.44M -65.61M -25.43M -321M -24.55M -24.02M -1.03B | -2.41M -2.14M -2M -1.83M -3.43M -232M -3.48M -24.19M -9.38M -118M -9.05M -8.85M -381M |
| Net Debt | 1.51M 1.35M 1.26M 1.15M 2.15M 146M 2.19M 15.19M 5.89M 74.34M 5.68M 5.56M 239M | 1.71M 1.52M 1.42M 1.3M 2.43M 165M 2.47M 17.16M 6.65M 83.96M 6.42M 6.28M 270M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change |
|---|---|---|
| 01/10/26 | CA$0.5500 | - |
| 30/09/26 | CA$0.000000 | - |
| 29/09/26 | CA$0.000000 | -100.00% |
| 25/09/26 | CA$0.4700 | +2.17% |
| 23/09/26 | CA$0.4600 | +9.52% |
- Stock Market
- Stocks
- VIBE Stock
- VIBE Stock
Select your edition
All financial news and data tailored to specific country editions

















